Product Information
CLINDA-TRETINOIN 1.2%-0.025% is a generic product labeled by Oceanside Pharmaceuticals, priced at $6.2993 per GM under NDC 68682030060. Its NADAC has been published 77 times since Apr 17, 2024.
FDA first approved this application on Nov 7, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12; .25 mg/g; mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682030060
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
CLINDAMYCIN PHOSPHATE; TRETINOINApproval Type
Authorized Generic (NDA)
FDA Application
NDA050802FDA Approved
11/7/2006
TE Code
AB1
On Market Since
8/4/2020
Pharmacological Classes
Price Statistics
The NADAC for CLINDA-TRETINOIN 1.2%-0.025% has been published 77 times since Apr 17, 2024, and over the history we have for it it has risen 18.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2993 per GM |
|---|---|
| All-time high | $6.9072 (Aug 13, 2025) |
| All-time low | $4.7546 (Oct 23, 2024) |
| Median price | $5.3369 |
| Average price | $5.6344 |
| Largest weekly change | +7.1% (May 21, 2025) |
| Weeks tracked | 77 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+18.0%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate and tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDA-TRETINOIN 1.2%-0.025%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDA-TRETINOIN 1.2%-0.025%, manufactured by Oceanside Pharmaceuticals, is $6.2993 per GM (NDC 68682030060), effective Oct 1, 2025.
How has the price of CLINDA-TRETINOIN 1.2%-0.025% changed over time?
Over the history we have for it, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has risen 18.0%. It has been tracked across 77 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CLINDA-TRETINOIN 1.2%-0.025%?
Since Apr 17, 2024, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has ranged from a low of $4.7546 (Oct 23, 2024) to a high of $6.9072 (Aug 13, 2025), with a median of $5.3369 per GM.
Are there cheaper alternatives to CLINDA-TRETINOIN 1.2%-0.025%?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDA-TRETINOIN 1.2%-0.025%, is $4.3997 per GM — about 30% below CLINDA-TRETINOIN 1.2%-0.025%.
Who manufactures CLINDA-TRETINOIN 1.2%-0.025%?
CLINDA-TRETINOIN 1.2%-0.025% (NDC 68682030060) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.